ivosedinib,azacitidine,ivosidenib
servier
['aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'leukemia', 'myeloid', 'leusm', 'agile', 'azacitidine,(-oral azaci),(-azacitidine oral)', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'ivosidenib']
significant clinical benefit shown with #ivosidenib plus #azacitidine vs placebo plus azacitidine in patients with newly-diagnosed idh1-mutant acute myeloid leukemia, according to findingd from the phase 3 agile trial. #asco22 #aml #leusm 
Oncology news and insights from leading researchers and cancer centers.